Co-Diagnostics submits FDA 510(k) for respiratory test

Reports

2

Domains carrying it

2

First reported

6 August 2026

Latest report

7 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 6 August 2026Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Testprnewswire.com
2. 7 August 2026Co-Diagnostics submits FDA 510(k) for respiratory testng.investing.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• Medibyt Receives FDA 510(k) Clearance for CPETWise, Advancing Cardiopulmonary ...5 reports · 5 domains · 4 September 2026
• FDA clears C2N Diagnostics' PrecivityAD2 blood test for Alzheimer's diagnosis in adults aged 40+11 reports · 11 domains · 4 September 2026
• Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary ...3 reports · 3 domains · 28 August 2026
• Freenome Lung Cancer Blood Test Receives FDA Breakthrough Device Status2 reports · 2 domains · 14 August 2026
• J&J's Monarch robot wins FDA nod for AI features4 reports · 4 domains · 18 August 2026
• FDA Floats Competency-Based Regs For Generative AI-Enabled Devices15 reports · 12 domains · 2 September 2026

◆ Share

◆ Evidence

2 reports · 2 domains

• Co-Diagnostics submits FDA 510(k) for respiratory testng.investing.com · 7 August 2026
• Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Testprnewswire.com · 6 August 2026